SKI Market

Indian Indices

Nifty

24,008.00 -265.80
(-1.10%)

Sensex

81,990.62 2,536.15
( 3.19%)

Bank Nifty

53,595.25 -770.40
( -1.42%)

Nifty IT

35,880.10 -122.35
( -0.34%)

Global Indices

Nasdaq

41,266.30 -123.15
(-0.30%)

Dow Jones

5,680.75 -4.19
(-0.07%)

Hang Seng

37,650.80 147.47
(0.39%)

Nikkei 225

8,554.80 23.19
(0.27%)

Forex

USD-INR

85.39 0.69
(0.81%)

EUR-INR

96.28 0.21
(0.22%)

GBP-INR

113.48 0.52
(0.46%)

JPY-INR

0.59 0.00
(-0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Biocon Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532523

INE376G01013

95.9811761

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BIOCON

39619.8

EPS(TTM)

Face Value()

Div & Yield %

0.41

0.38

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	2127.30	1992.90	1738.20	2028.40	1988.40	1785.70
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	2127.30	1992.90	1738.20	2028.40	1988.40	1785.70
Other Income	207.50	3134.20	187.20	150.20	366.00	422.00
Stock Adjustments	99.10	-3.20	105.80	-36.70	31.40	69.10
Total Income	2433.90	5123.90	2031.20	2141.90	2385.80	2276.80
EXPENDITURE :
Raw Materials	1033.80	981.00	914.00	761.60	859.10	857.60
Power & Fuel Cost	215.30	279.20	231.00	186.00	193.30	152.40
Employee Cost	452.30	433.80	367.70	390.20	344.80	289.10
Other Manufacturing Expenses	155.40	127.10	130.50	147.00	118.30	104.30
Selling & Administrative Expenses	135.00	112.20	106.70	128.40	208.40	222.40
Miscellaneous Expenses	-28.10	32.90	33.00	66.00	9.90	18.70
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1963.70	1966.20	1782.90	1679.20	1733.80	1644.50
Operating Profit	470.20	3157.70	248.30	462.70	652.00	632.30
Interest	198.80	69.60	0.40	0.40	1.20	2.60
Gross Profit	271.40	3088.10	247.90	462.30	650.80	629.70
Depreciation	121.10	116.90	108.20	103.50	98.00	92.30
Profit Before Tax	150.30	2971.20	139.70	358.80	552.80	537.40
Tax	15.10	132.70	60.70	73.50	104.40	54.60
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	15.90	-9.90	-7.10	4.80	7.50	-9.90
Reported Net Profit	119.30	2848.40	86.10	280.50	440.90	492.70
Extraordinary Items	13.41	2861.73	2.92	3.00	136.27	166.64
Adjusted Net Profit	105.89	-13.33	83.18	277.50	304.63	326.06
Adjustment below Net Profit	30.70	29.40	-59.40	30.40	22.60	-51.80
P & L Balance brought forward	9950.60	7132.80	7106.10	6795.20	6391.80	6020.60
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	180.10	60.00	0.00	0.00	60.10	69.40
P & L Balance carried down	9920.50	9950.60	7132.80	7106.10	6795.20	6392.10
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	10.00	30.00	10.00	0.00	0.00	20.00
Dividend Per Share(Rs)	0.50	1.50	0.50	0.00	0.00	1.00
Earnings Per Share-Unit Curr	0.99	23.72	0.72	2.34	3.67	8.21
Earnings Per Share(Adj)-Unit Curr	0.99	23.72	0.72	2.34	3.67	4.11
Book Value-Unit Curr	90.88	90.91	67.40	65.88	62.80	118.58
Book Value(Adj)-Unit Curr	90.88	90.91	67.40	65.88	62.80	59.29

24,008.00 -265.80 (-1.10%)

81,990.62 2,536.15 ( 3.19%)

53,595.25 -770.40 ( -1.42%)

35,880.10 -122.35 ( -0.34%)

41,266.30 -123.15 (-0.30%)

5,680.75 -4.19 (-0.07%)

37,650.80 147.47 (0.39%)

8,554.80 23.19 (0.27%)

85.39 0.69 (0.81%)

96.28 0.21 (0.22%)

113.48 0.52 (0.46%)

0.59 0.00 (-0.21%)